Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
Rhea-AI Summary
Jazz Pharmaceuticals (Nasdaq:JAZZ) announced that management will join fireside chats at three upcoming investor events: the 2026 RBC Global Healthcare Conference on May 19, 2026 at 8:00 a.m. ET, the Cowen 7th Annual Oncology Innovation Summit on May 27, 2026 at 2:00 p.m. ET, and the 2026 Jefferies Global Healthcare Conference on June 3, 2026 at 10:30 a.m. ET.
Audio webcasts will be accessible through the Investors section of Jazz Pharmaceuticals’ website, with replays available for 30 days.
Positive
- None.
Negative
- None.
News Market Reaction – JAZZ
In the May 13 session, JAZZ gained 1.97%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- 2026 RBC Global Healthcare Conference on Tuesday, May 19, 2026 at 8:00 a.m. ET
- TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA on Wednesday, May 27, 2026 at 2:00 p.m. ET
- 2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026 at 10:30 a.m. ET
Audio webcasts of the fireside chats will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations. A replay of the webcasts will be archived on the website for 30 days.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with rare disease — often with limited or no therapeutic options. We have a diverse portfolio of medicines, including leading therapies addressing epilepsies, cancers and sleep disorders. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.
Contacts
Investors:
InvestorInfo@jazzpharma.com
Media:
CorporateAffairsMediaInfo@jazzpharma.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-upcoming-investor-conferences-302768975.html
SOURCE Jazz Pharmaceuticals plc
